Integrity Alliance’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.7K Hold
57,300
﹤0.01% 841
2026
Q1
$34.8K Hold
57,300
﹤0.01% 745
2025
Q4
$55K Hold
57,300
﹤0.01% 772
2025
Q3
$99.7K Sell
57,300
-4,290
-7% -$8.4K ﹤0.01% 548
2025
Q2
$129K Sell
61,590
-3,977
-6% -$7.64K 0.01% 464
2025
Q1
$112K Buy
+65,567
New +$246K ﹤0.01% 619

Other funds holding HUMA

Integrity Alliance's HUMA Position: Q2 2026 in Review

Integrity Alliance held its Humacyte (HUMA) position steady in Q2 2026 at 57,300 shares worth $44.7K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Integrity Alliance first reported a position in HUMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $129K in Q2 2025. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Integrity Alliance held 57,300 shares of Humacyte worth $44.7K as of Q2 2026.
  • Integrity Alliance left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up ﹤0.01% of Integrity Alliance's portfolio in Q2 2026, its #841 holding.
  • Integrity Alliance first reported a position in Humacyte in Q1 2025 and has held it in 6 quarters since.
  • Integrity Alliance's Humacyte position peaked at $129K in Q2 2025.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Integrity Alliance's 13F filing for Q2 2026, filed 31 Jul 2026.